Mentari Therapeutics Inc MTRI
News
Trading Information
- Previous Close Price
- $15.61
- Day Range
- $14.76–18.90
- 52-Week Range
- $5.75–23.30
- Bid/Ask
- $16.56 / $18.30
- Shares Outstanding
- 58.30M
- Market Cap
- $1.07B
- Volume/Avg
- 35,758 / 10,016
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Mentari Therapeutics Inc is a biotechnology company engaged in the development of therapies for the prevention of migraine. Its product pipeline includes MT-001, an anti-PACAP monoclonal antibody, and MT-002, a bispecific antibody targeting both CGRP and PACAP pathways. The company's research and development activities focus on therapeutic candidates targeting PACAP and CGRP-related mechanisms for migraine prevention.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.mentaritx.com
Valuation
Metric | MTRI |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | MTRI |
|---|---|
Quick Ratio | 2.10 |
Current Ratio | 2.10 |
Interest Coverage | — |
Quick Ratio
MTRI
Profitability
Metric | MTRI |
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|npVzHB& | LOCK|d%cdK | $139B | |||
| Moderna Inc MRNA | LOCK|$Q^f$T | LOCK|j<@ | $101B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|&K&MY!p | LOCK|B<ry | $99B | |||
| argenx SE ADR ARGX | LOCK|<F%bf<f | LOCK|#@g | $61B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|?r<rcM | LOCK|mz# | $49B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|HTJbQfjt | LOCK|hzx%> | $31B | |||
| Incyte Corp INCY | LOCK|Xv<Q$@ | LOCK|$W | $25B | |||
| BioNTech SE ADR BNTX | LOCK|%@&mt> | LOCK|rG | $22B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|Y$NpM#^ | LOCK|kWj^c | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|%^%hS^M | LOCK|Cg> | $16B |
United States